Clinical Trials Ontario

Clinical Trials Ontario
Name	Clinical Trials Ontario
Formation	2015
Type	Not-for-profit organization
Headquarters	Ontario, Canada
Region served	Ontario

Clinical Trials Ontario is an organization established to streamline and coordinate clinical research approvals across Ontario. It was created to harmonize review processes between institutions such as University of Toronto, McMaster University, Queen's University and health authorities like Toronto General Hospital, Hamilton Health Sciences and Sunnybrook Health Sciences Centre. The agency engages stakeholders including funders such as the Canadian Institutes of Health Research, industry sponsors like Pfizer, and patient groups such as the Canadian Cancer Society.

History

Clinical Trials Ontario originated from provincial policy initiatives and operational reviews influenced by reports from entities like the Ministry of Health and Long-Term Care (Ontario), the Canadian Institutes of Health Research, and health research commissions. Early pilots involved academic centres including Western University, Ottawa Hospital Research Institute and St. Michael's Hospital, with governance models referencing examples from National Institutes of Health, Health Canada, and international partners such as the National Institute for Health and Care Research. The initiative evolved through consultations with institutional review boards from centres like SickKids Research Institute and ethics committees associated with Mount Sinai Hospital (Toronto), responding to critiques from peak bodies including the Canadian Medical Association and standards promoted by the Tri-Council Policy Statement: Ethical Conduct for Research Involving Humans.

Structure and Governance

The organization is governed by a board drawing expertise from universities including McGill University and University of British Columbia, health networks like North York General Hospital and patient advocates from charities such as Heart and Stroke Foundation of Canada. Operational leadership links to executive teams with experience at research institutions such as Princess Margaret Cancer Centre and coordination roles interfacing with regulators including Health Canada and funding agencies such as the Ontario Institute for Cancer Research. Committees mirror models used by the World Health Organization and advisory panels reflect participation from law schools and policy units at Osgoode Hall Law School and Munk School of Global Affairs and Public Policy.

Functions and Services

Clinical Trials Ontario provides centralized services for multisite research approvals, adopting processes similar to single-review models used by National Institute for Health Research and multisite ethics review frameworks at Cancer Research UK. Core services include centralized research ethics review coordination for hospitals such as London Health Sciences Centre and enabling logistics for sponsors like Roche and research networks like the Canadian Cancer Trials Group. Additional offerings include training modules drawing on curricula from CIHR, data-sharing arrangements consonant with standards from institutions such as ICES (Institute for Clinical Evaluative Sciences), and site feasibility services used by academic sponsors including McMaster University Medical Centre.

Regulatory and Ethical Framework

The organization operates within provincial statutes and federal regulations administered by Health Canada and follows ethical guidance from the Panel on Research Ethics (Canada). Its review model integrates considerations from policy instruments like the Personal Health Information Protection Act, 2004 and aligns with international norms exemplified by the Declaration of Helsinki and guidance from the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use. Ethics boards participating in the system include those from Hamilton Health Sciences and Trillium Health Partners, applying standards similar to those upheld by the U.S. Food and Drug Administration and scrutiny comparable to that of the European Medicines Agency.

Partnerships and Collaborations

The organization collaborates with academic partners such as Sunnybrook Research Institute, community hospitals like William Osler Health System, and research networks including the Canadian Institutes of Health Research Clinical Trials Network. Industry partners have included multinational firms such as Novartis and biotechnology companies akin to Amgen, while philanthropic collaborators feature organizations like the Canadian Cancer Society and foundations modeled on Michael Smith Foundation for Health Research. International linkages include exchanges with agencies such as the National Institute for Health Research and policy dialogues with the World Health Organization to align cross-jurisdictional trial conduct.

Impact and Metrics

Performance metrics reported by the organization emphasize reduced approval timelines, increased multisite trial activation across centres like Ottawa Hospital and Hamilton Health Sciences, and enhanced recruitment for studies led by investigators at University Health Network. Outcome measures reference trial startup indicators used by ClinicalTrials.gov and benchmarking against datasets from the Canadian Cancer Trials Group. Evaluations cite improvements in trial initiation comparable to reforms championed at institutions such as Vancouver Coastal Health and continuous quality improvement informed by methodologies from Institute for Healthcare Improvement.

Category:Health research in Ontario